home / stock / adilw / adilw news


ADILW News and Press, Adial Pharmaceuticals Inc Warrant From 03/25/19

Stock Information

Company Name: Adial Pharmaceuticals Inc Warrant
Stock Symbol: ADILW
Market: NASDAQ
Website: adialpharma.com

Menu

ADILW ADILW Quote ADILW Short ADILW News ADILW Articles ADILW Message Board
Get ADILW Alerts

News, Short Squeeze, Breakout and More Instantly...

ADILW - Adial Pharmaceuticals Announces Filing to Update the Prior Registration Statement Registering the Shares Underlying the ADILW Warrants

CHARLOTTESVILLE, VA / ACCESSWIRE / March 25, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, announced today that it filed a Registration Statement on Form S-1 on March 22, 2019, to ...

ADILW - Adial Pharmaceuticals Featured on CBS in San Francisco

CHARLOTTESVILLE, Va., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, announced that William Stilley, President and Chief Executive Officer, appeared ...

ADILW - Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters' Over-Allotment Option

Proceeds from Offering Expected to Fully Fund Initial Phase 3 Trial of AD04 CHARLOTTESVILLE, Va., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, anno...

ADILW - Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

CHARLOTTESVILLE, Va., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced the pricing of an underwritten public offering of 2,475,000 shares of ...

ADILW - Adial Pharmaceuticals Announces Partnership with Catalent to Package and Distribute Adial's AD04 for its Phase 3 Trial

CHARLOTTESVILLE, Va., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW) www.adialpharma.com , a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced a partnership with Catalent Pharma Solutions, ...

ADILW - Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence and Abuse

Continuation patent would allow for broader protection  beyond claims protected under current patents CHARLOTTESVILLE, Va., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW) , a clinical-stage biopharmaceutical company focused on the developm...

ADILW - Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

Distinguished Professor Markus Heilig joins an accomplished assemblage of addiction specialists including Dr. Giovanni Addolorato and Professors Hannu Alho, Tomas Zima and Sebastian Mueller CHARLOTTESVILLE, Va., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ...

ADILW - Dr. Bankole A. Johnson, Chairman of Adial Pharmaceuticals, Receives Prestigious American Society of Addiction Medicine Award

Dr. Johnson Recognized for Advancing Scientific Understanding of Alcoholism and its Prevention CHARLOTTESVILLE, Va., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatme...

ADILW - Adial Pharmaceuticals CEO to Appear on CBS and Fox Affiliates to Discuss AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder

Scheduled to appear today on KSWB-TV FOX 5 Morning News in San Diego at 10:40 AM ET/7:40 AM PT Additional appearance scheduled on KPIX-TV (CBS-CW) “Bay Area Focus” morning show February 3 rd during the 2:00 PM ET/11:00 AM PT hour CHARLOTTESVILLE, Va., Feb. 01, 2019 (GLOBE...

Previous 10 Next 10